圆缘园
Lv3
260 积分
2023-03-13 加入
-
Immunotherapy combinations overcome resistance to bispecific T cell engager treatment in T cell–cold solid tumors
18天前
已完结
-
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
1个月前
已完结
-
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
-
PROTACs Targeting BRM (SMARCA2) Afford Selective In Vivo Degradation over BRG1 (SMARCA4) and Are Active in BRG1 Mutant Xenograft Tumor Models
1个月前
已完结
-
Tumor-Specific Activation of an EGFR-Targeting Probody Enhances Therapeutic Index
1个月前
已完结
-
Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure
1个月前
已完结
-
GIPR/GLP-1R dual agonist therapies for diabetes and weight loss—chemistry, physiology, and clinical applications
1个月前
已完结
-
Investigations into the actions of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1(7-36)amide on lipoprotein lipase activity in explants of rat adipose tissue
2个月前
已关闭
-
Discovery of (S)-1-((2′,6-Bis(difluoromethyl)-[2,4′-bipyridin]-5-yl)oxy)-2,4-dimethylpentan-2-amine (BMS-986176/LX-9211): A Highly Selective, CNS Penetrable, and Orally Active Adaptor Protein-2 Associated Kinase 1 Inhibitor in Clinical Trials for the Treatment of Neuropathic Pain
2个月前
已完结
-
Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor
3个月前
已完结